Nexalin Technology Inc (NXL)

Currency in USD
3.6300
-0.4800(-11.68%)
Closed·
3.7500+0.1200(+3.31%)
·
Trading near 52-week Low
NXL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.50003.9500
52 wk Range
3.500050.7000
Key Statistics
Prev. Close
3.63
Open
3.95
Day's Range
3.5-3.95
52 wk Range
3.5-50.7
Volume
68.29K
Average Volume (3m)
1.01M
1-Year Change
-90.5469%
Book Value / Share
2.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NXL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.0000
Upside
+313.22%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Nexalin Technology Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 15.0000
(+313.22% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy15.00+313.22%-MaintainOct 01, 2026
Maxim Group
Buy2.00-44.90%4.00MaintainApr 07, 2026

Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-0.11 / -0.10
Revenue / Forecast
12.16K / 90K
EPS Revisions
Last 90 days

NXL Income Statement

Compare NXL to Peers and Sector

Metrics to compare
NXL
Peers
Sector
Relationship
P/E Ratio
−0.3x−2.0x−0.3x
PEG Ratio
−0.01−0.100.00
Price/Book
2.0x3.9x2.6x
Price / LTM Sales
13.9x2.1x3.0x
Upside (Analyst Target)
313.2%118.4%61.4%
Fair Value Upside
Unlock4.4%7.4%Unlock

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.24K1.23%37.16K
Other Institutional Investors
225.50K27.19%818.58K
Public Companies & Retail Investors
593.66K71.58%2.15M
Total
829.4K100.00%3.01M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Alumni Capital LP9.72%80,645293
Alumni Capital Management9.72%80,645293

People Also Watch

0.418
GIPR
-9.14%
1.5800
IMCC
-8.14%
1.42
PFSA
-4.70%
0.0721
NIVF
-11.10%
2.19
AMOD
-6.01%

FAQ

What Is the Nexalin Technology (NXL) Stock Price Today?

The Nexalin Technology stock price today is 3.6300 USD.

What Stock Exchange Does Nexalin Technology Trade On?

Nexalin Technology is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nexalin Technology?

The stock symbol for Nexalin Technology is "NXL."

What Is the Nexalin Technology Market Cap?

As of today, Nexalin Technology market cap is 3.4100M USD.

What Is Nexalin Technology's Earnings Per Share (TTM)?

The Nexalin Technology EPS (TTM) is -13.9203.

When Is the Next Nexalin Technology Earnings Date?

Nexalin Technology will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is NXL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nexalin Technology Stock Split?

Nexalin Technology has split 1 times.

What is the current trading status of Nexalin Technology (NXL)?

As of Oct 10, 2026, Nexalin Technology (NXL) is trading at a price of 3.6300 USD, with a previous close of 3.6300 USD. The stock has fluctuated within a day range of 3.5000 USD to 3.9500 USD, while its 52-week range spans from 3.5000 USD to 50.7000 USD.

What Is Nexalin Technology (NXL) Price Target According to Analysts?

The average 12-month price target for Nexalin Technology is 15.0000 USD, with a high estimate of 15 USD and a low estimate of 15 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +313.22% Upside potential.

What Is the NXL Premarket Price?

NXL's last pre-market stock price is 4.0000 USD. The pre-market share volume is 3,630.0000, and the stock has decreased by -0.1100, or -2.6800%.

What Is the NXL After Hours Price?

NXL's last after hours stock price is 3.7500 USD, the stock has decreased by 0.1200, or 3.3100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.